CNBC Fast Money
2026-05-15 · Hosted by Melissa Lee · CNBC
Executive Summary
The trading desk dissected a euphoric session: Cerebras closed +68% at ~$311 in the largest semiconductor IPO ever; Dow reclaimed 50,000, S&P closed above 7,500 for the first time, Nasdaq at record highs. Nvidia added a 7-day winning streak with a market cap above $5.7 trillion, and Cisco had its best day in 15 years. Multiple guests cautioned that day-one Cerebras buyers above $300 may be left holding the bag, comparing the pattern to Figma, Clarna, and CoreWeave. Trump’s China visit produced a 200-jet Boeing commitment (vs. expected 500) but no breakthrough on Taiwan. The Senate Banking Committee advanced the bipartisan Clarity Act for crypto regulation.
Key Stories & Changes
1. Cerebras Debut — The Biggest Tech IPO of 2026
Priced $185, opened at $350, intraday peak $385, closed +68% at ~$311
Largest US tech IPO since Snowflake; largest semiconductor IPO ever
Fully diluted valuation ~$117 billion at peak, 228x last year’s $510M revenue
Backlog: $24.5 billion, with $20 billion from OpenAI alone
Morgan Stanley estimates ~$15 billion in revenue over next 3 years (vs. $510M in 2025)
Three customer buckets: labs (OpenAI), nations (UAE), cloud (AWS, terms TBD)
Gil Luria (DA Davidson, not yet covering): fair value ~$115/share (1x backlog), bull case = “Bugatti for inference,” bear case = “Concorde — niche too small”
Tiger Global made ~$1 billion in 7 months on its position
2. Earnings & After-Hours Movers
CRBS: Cerebras — +68% — Biggest tech IPO of year; OpenAI/AWS/UAE concentration
AMAT: Applied Materials — Higher AH — Record top/bottom; sees multi-year revenue/profit growth on AI boom
FIG: Figma — +9% AH — Beat earnings/revenue, raised guidance
NVDA: Nvidia — +4% — Market cap >$5.7T; 7-day winning streak
CSCO: Cisco — +15% — Best day in 15 years on AI infrastructure demand
BIIB: Biogen — -6% — Phase 2 Alzheimer’s missed primary endpoint, advancing to Phase 3 anyway
3. Biogen Alzheimer’s Trial Whipsaw
Stock initially +10%, closed down 6%
Phase 2 trial missed primary goal of dose-response, but Biogen says lower dose showed cognitive benefit and reduced tau protein
Tim Seymour: trades 11x next year, multiple viable drugs; selloff overdone
Carter Worth: bullish-to-bullish reversal pattern, headed higher
4. Trump-Xi Summit
Trump claims China agreed to buy 200 Boeing jets (down from 500 expected)
Xi pledged no military equipment to Iran, but China continues buying Iranian oil
Xi warned Trump that mishandling Taiwan could trigger “collision or conflict”
US readout omitted Taiwan; Trump declined to answer reporter questions on Taiwan
90% of world’s chips produced in Taiwan — leverage clearly Xi’s, not Trump’s
5. Ford Energy Hype
Ford +20% over two days on Ford Energy launch and CATL battery partnership
Morgan Stanley applied 17.5x multiple on a $10B EV storage business
Tim Seymour: prefers GM (six times forward earnings, never been more profitable)
Carter Worth: F-150 EB was “most exciting car in EV market”
6. Crypto Clarity Act Advances
Senate Banking Committee approved on bipartisan basis
Allows rewards for using/spending stablecoins, not for holding them
Banks warn of loopholes; lobbying battle continues
Coinbase, Robinhood rallied; Bitcoin nearing $82K
Tim Seymour: prefers Coinbase over Bitcoin if directional bullish
7. China Internet Trade
KWEB (China internet ETF) had its worst day of the year, -4%
Carter Worth: time to buy — 36% drawdown, 52-week lows, asymmetrical setup
Multiple line-drawing techniques (downtrend, ascending triangle, wedge) all suggest reversal
8. Software Bounce
IGV up 2% today, +20% off April $74 low (now ~$90)
ServiceNow and “MicroStrategy” (Strategy) outperforming
Carter Worth: classic bearish-to-bullish reversal in IGV
Stuart Kaiser (Citi): cautious — needs sentiment shift, biggest short on price momentum
9. Mark Jacobs Sale
LVMH selling Mark Jacobs to brand management firm WHP Global, ending nearly 30-year partnership
Mark Jacobs remains creative director; deal terms undisclosed
Will push WHP global retail sales above $9.5 billion alongside Vera Wang and Rag & Bone
Trends Identified
1. The Bagholder Pattern in 2026 IPOs
The desk explicitly flagged a recurring pattern: Figma, eToro, Clarna, CoreWeave all peaked on day one or two after IPO. Cerebras’s intraday peak above $385 fits the template. Tim Seymour predicted Cerebras could trade back at IPO price within 3 weeks — a structural caution about hot AI debuts when day-one demand becomes day-three supply.
2. Memory as the Tightest AI Bottleneck
Multiple panelists agreed memory is the most constrained input — Samsung and SK Hynix have indicated no new supply until end of 2026. This drives both micron’s appeal at 8x earnings and Cerebras’s value proposition (memory on the wafer eliminates KV cache shuttling). Stuart Kaiser (Citi) cited memory as Goldman’s “tightest bottleneck.”
3. AI as the Only Trade
Multiple references to AI being effectively the entire market story. Even traditionally non-tech names (Ford via Ford Energy) are getting bid because investors are looking for “the next data center play” and stumbling onto adjacent businesses.
4. Taiwan as China’s Trump Card
The asymmetry of leverage was repeatedly noted: with TSMC producing 90% of advanced chips, China holds the strategic card on Taiwan, not the US. The US cannot allow Chinese control of Taiwanese fabs, but the market hasn’t priced in this binary risk.
5. Concorde vs Bugatti Framing for AI Chips
DA Davidson’s Gil Luria framed the Cerebras debate as Bugatti (premium speed niche) vs. Concorde (too narrow to scale). The framework applies broadly to AI hardware: which companies have a real moat versus which are over-extrapolating a temporary memory tightness? —-
Sentiment Analysis
Overall Market Sentiment: Euphoric, Cautious Underneath
Records across major indices and historic IPO debut, but the desk consistently flagged valuation, concentration, and technical concerns about retail buyers entering at the top.
Risk Factors Highlighted
Cerebras lock-up & dilution: 84M shares unlock end of August, 80M more in September
OpenAI execution risk on $20B contract: Cerebras 86% concentrated in two UAE customers last year
Vera Rubin competition: Nvidia’s next chip closes the speed gap
Day-one Cerebras buyers: Pattern from Figma/Clarna/CoreWeave suggests near-term downside
Memory price reversal: Cerebras advantage partially predicated on current memory tightness
Taiwan blockade scenario: Could blow up the entire AI complex
Iran/Strait of Hormuz: Oil priced at $100/bbl; Trump-Xi deal vague on real cooperation
Boeing disappointment: 200 jets vs. expected 500 — incremental but underwhelming
Software sentiment: Biggest short on price momentum, requires sentiment shift to break out
Biotech failure pattern: Biogen’s history (adu-helm) makes investors skeptical of Phase 2-to-3 messaging
This episode was covered in today’s The Market Signal — 2026-05-15, a cross-source synthesis of multiple podcast reports.